Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial

1. Borras JM, Barton M, Grau C, Corral J, Verhoeven R, Lemmens V, et al. The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project. Radiother Oncol 2015; 116: 45–50. doi: 10.1016/j.radonc.2015.04.021 BorrasJM BartonM GrauC CorralJ VerhoevenR LemmensV The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project Radiother Oncol 2015 116 45 50 10.1016/j.radonc.2015.04.021 Open DOISearch in Google Scholar

2. Peng X, Wu Y, Brouwer U, van Vliet T, Wang B, Demaria M, et al. Cellular senescence contributes to radiation-induced hyposalivation by affecting the stem/progenitor cell niche. Cell Death Dis 2020; 11: 854. doi: 10.1038/s41419-020-03074-9 PengX WuY BrouwerU van VlietT WangB DemariaM Cellular senescence contributes to radiation-induced hyposalivation by affecting the stem/progenitor cell niche Cell Death Dis 2020 11 854 10.1038/s41419-020-03074-9 Open DOISearch in Google Scholar

3. Siddiqui F, Movsas B. Management of radiation toxicity in head and neck cancers. Semin Radiat Oncol 2017; 27: 340–9. doi: 10.1016/j.semradonc.2017.04.008 SiddiquiF MovsasB Management of radiation toxicity in head and neck cancers Semin Radiat Oncol 2017 27 340 9 10.1016/j.semradonc.2017.04.008 Open DOISearch in Google Scholar

4. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 2004; 26: 796–807. doi: 10.1002/hed.20045 ChambersMS GardenAS KiesMS MartinJW Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management Head Neck 2004 26 796 807 10.1002/hed.20045 Open DOISearch in Google Scholar

5. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127–36. doi: 10.1016/S1470-2045(10)70290-4 NuttingCM MordenJP HarringtonKJ UrbanoTG BhideSA ClarkC Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Lancet Oncol 2011 12 127 36 10.1016/S1470-2045(10)70290-4 Open DOISearch in Google Scholar

6. Nuyts S, Bollen H, Ng SP, Corry J, Eisbruch A, Mendenhall WM, et al. Proton therapy for squamous cell carcinoma of the head and neck: early clinical experience and current challenges. Cancers 2022; 14: 2587. doi: 10.3390/cancers14112587 NuytsS BollenH NgSP CorryJ EisbruchA MendenhallWM Proton therapy for squamous cell carcinoma of the head and neck: early clinical experience and current challenges Cancers 2022 14 2587 10.3390/cancers14112587 Open DOISearch in Google Scholar

7. Chen D, Chen X, Chen X, Jiang N, Jiang L. The efficacy of positioning stents in preventing oral complications after head and neck radiotherapy: a systematic literature review. Radiat Oncol 2020; 15: 90. doi: 10.1186/s13014-020-01536-0 ChenD ChenX ChenX JiangN JiangL The efficacy of positioning stents in preventing oral complications after head and neck radiotherapy: a systematic literature review Radiat Oncol 2020 15 90 10.1186/s13014-020-01536-0 Open DOISearch in Google Scholar

8. Riley P, Glenny AM, Hua F, Worthington HV. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy. Cochrane Database Syst Rev 2017; 7: CD012744. doi: 10.1002/14651858.CD012744 RileyP GlennyAM HuaF WorthingtonHV Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy Cochrane Database Syst Rev 2017 7 CD012744 10.1002/14651858.CD012744 Open DOISearch in Google Scholar

9. Sood AJ, Fox NF, O’Connell BP, Lovelace TL, Nguyen SA, Sharma AK, et al. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis. Oral Oncol 2014; 50: 77–83. doi: 10.1016/j.oraloncology.2013.10.010 SoodAJ FoxNF O’ConnellBP LovelaceTL NguyenSA SharmaAK Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis Oral Oncol 2014 50 77 83 10.1016/j.oraloncology.2013.10.010 Open DOISearch in Google Scholar

10. Strojan P, Hutcheson KA, Eisbruch A, Beitler JJ, Langendijk JA, Lee AWM, et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treat Rev 2017; 59: 79–92. doi: 10.1016/j.ctrv.2017.07.003 StrojanP HutchesonKA EisbruchA BeitlerJJ LangendijkJA LeeAWM Treatment of late sequelae after radiotherapy for head and neck cancer Cancer Treat Rev 2017 59 79 92 10.1016/j.ctrv.2017.07.003 Open DOISearch in Google Scholar

11. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008; 26: 3770–6. doi: 10.1200/JCO.2007.14.6647 LangendijkJA DoornaertP Verdonck-de LeeuwIM LeemansCR AaronsonNK SlotmanBJ Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 2008 26 3770 6 10.1200/JCO.2007.14.6647 Open DOISearch in Google Scholar

12. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726–36. doi: 10.1038/nri2395 UccelliA MorettaL PistoiaV Mesenchymal stem cells in health and disease Nat Rev Immunol 2008 8 726 36 10.1038/nri2395 Open DOISearch in Google Scholar

13. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315–7. doi: 10.1080/14653240600855905 DominiciM Le BlancK MuellerI Slaper-CortenbachI MariniF KrauseD Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 2006 8 315 7 10.1080/14653240600855905 Open DOISearch in Google Scholar

14. Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif 2020; 53: e12712. doi: 10.1111/cpr.12712 JiangW XuJ Immune modulation by mesenchymal stem cells Cell Prolif 2020 53 e12712 10.1111/cpr.12712 Open DOISearch in Google Scholar

15. Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life 2017; 74: 2345–60. doi: 10.1007/s00018-017-2473-5 LiN HuaJ Interactions between mesenchymal stem cells and the immune system Cell Mol Life 2017 74 2345 60 10.1007/s00018-017-2473-5 Open DOISearch in Google Scholar

16. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838–43. doi: 10.1182/blood.v99.10.3838 Di NicolaM Carlo-StellaC MagniM MilanesiM LongoniPD MatteucciP Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 2002 99 3838 43 10.1182/blood.v99.10.3838 Open DOISearch in Google Scholar

17. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389–97. doi: 10.1097/01.TP.0000045055.63901.A9 TseWT PendletonJD BeyerWM EgalkaMC GuinanEC Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 2003 75 389 97 10.1097/01.TP.0000045055.63901.A9 Open DOISearch in Google Scholar

18. Roncarolo MG, Gregori S, Bacchetta R, Battaglia M. Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. In: Fillatreau S, O’Garra A, editors. Interleukin-10 in health and disease. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. p. 39–68. doi: https://doi.org/10.1007/978-3-662-43492-5 RoncaroloMG GregoriS BacchettaR BattagliaM Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications In: FillatreauS O’GarraA editors. Interleukin-10 in health and disease Berlin, Heidelberg Springer Berlin Heidelberg 2014 39 68 doi: https://doi.org/10.1007/978-3-662-43492-5 Search in Google Scholar

19. Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76: 1208–13. doi: 10.1097/01.TP.0000082540.43730.80 RasmussonI RingdenO SundbergB Le BlancK Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells Transplantation 2003 76 1208 13 10.1097/01.TP.0000082540.43730.80 Open DOISearch in Google Scholar

20. Angoulvant D, Clerc A, Benchalal S, Galambrun C, Farre A, Bertrand Y, et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology 2004; 41: 469–76. PMID: 15299278 AngoulvantD ClercA BenchalalS GalambrunC FarreA BertrandY Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens Biorheology 2004 41 469 76 15299278 Search in Google Scholar

21. Zha K, Li X, Yang Z, Tian G, Sun Z, Sui X, et al. Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application. NPJ Regen Med 2021; 6: 14. doi: 10.1038/s41536-021-00122-6 ZhaK LiX YangZ TianG SunZ SuiX Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application NPJ Regen Med 2021 6 14 10.1038/s41536-021-00122-6 Open DOISearch in Google Scholar

22. Cottle C, Porter AP, Lipat A, Turner-Lyles C, Nguyen J, Moll G, et al. Impact of cryopreservation and freeze-thawing on therapeutic properties of mesenchymal stromal/stem cells and other common cellular therapeutics. Curr Stem Cell Rep 2022; 8: 72–92. doi: 10.1007/s40778-022-00212-1 CottleC PorterAP LipatA Turner-LylesC NguyenJ MollG Impact of cryopreservation and freeze-thawing on therapeutic properties of mesenchymal stromal/stem cells and other common cellular therapeutics Curr Stem Cell Rep 2022 8 72 92 10.1007/s40778-022-00212-1 Open DOISearch in Google Scholar

23. Krampera M, Le Blanc K. Mesenchymal stromal cells: putative microenviron-mental modulators become cell therapy. Cell Stem Cell 2021; 28: 1708–25. doi: 10.1016/j.stem.2021.09.006 KramperaM Le BlancK Mesenchymal stromal cells: putative microenviron-mental modulators become cell therapy Cell Stem Cell 2021 28 1708 25 10.1016/j.stem.2021.09.006 Open DOISearch in Google Scholar

24. National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, 2017. [cited 2023 Apr 14]. Available at: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 2017 [cited 2023 Apr 14]. Available at: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf Search in Google Scholar

25. Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 1982; 61: 1158–62. doi: 10.1177/00220345820610100901 NavazeshM ChristensenCM A comparison of whole mouth resting and stimulated salivary measurement procedures J Dent Res 1982 61 1158 62 10.1177/00220345820610100901 Open DOISearch in Google Scholar

26. Goličnik M, Bavec A. Evaluation of the paraoxonase-1 kinetic parameters of the lactonase activity by nonlinear fit of progress curves. J Enzyme Inhib Med Chem 2020; 35: 261–4. doi: 10.1080/14756366.2019.1695792 GoličnikM BavecA Evaluation of the paraoxonase-1 kinetic parameters of the lactonase activity by nonlinear fit of progress curves J Enzyme Inhib Med Chem 2020 35 261 4 10.1080/14756366.2019.1695792 Open DOISearch in Google Scholar

27. Petrič B, Goličnik M, Bavec A. iFIT: an automated web tool for determining enzyme-kinetic parameters based on the high-curvature region of progress curves. Acta Chim Slov 2022; 69: 478–82. doi: 10.17344/acsi.2022.7359 PetričB GoličnikM BavecA iFIT: an automated web tool for determining enzyme-kinetic parameters based on the high-curvature region of progress curves Acta Chim Slov 2022 69 478 82 10.17344/acsi.2022.7359 Open DOISearch in Google Scholar

28. Petrič B, Redenšek Trampuž S, Dolžan V, Gregorič Krambergar M, Trošt M, Makarović N, et al. Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in parkinson's disease. Antioxidants 2023; 12: 399. doi: 10.3390/antiox12020399 PetričB Redenšek TrampužS DolžanV Gregorič KrambergarM TroštM MakarovićN Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in parkinson's disease Antioxidants 2023 12 399 10.3390/antiox12020399 Open DOISearch in Google Scholar

29. Pai S, Ghezzi EM, Ship JA. Development of a Visual Analogue Scale questionnaire for subjective assessment of saliveary dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 311–6. doi: 10.1067/moe.2001.111551 PaiS GhezziEM ShipJA Development of a Visual Analogue Scale questionnaire for subjective assessment of saliveary dysfunction Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 91 311 6 10.1067/moe.2001.111551 Open DOISearch in Google Scholar

30. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-spearing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50: 695–704. doi: 10.1016/s0360-3016(01)01512-7 EisbruchA KimHM TerrellJE MarshLH DawsonLA ShipJA Xerostomia and its predictors following parotid-spearing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 2001 50 695 704 10.1016/s0360-3016(01)01512-7 Open DOISearch in Google Scholar

31. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A; EORTC Quality of Life Group. The EORTC QLQ-C30 Scoring manual. 3rd edition. Brussels: European Organisation for Research and Treatment of Cancer; 2001. FayersPM AaronsonNK BjordalK GroenvoldM CurranD BottomleyA EORTC Quality of Life Group The EORTC QLQ-C30 Scoring manual 3rd edition Brussels European Organisation for Research and Treatment of Cancer 2001 Search in Google Scholar

32. Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci 2013; 14: 17986–8001. doi: 10.3390/ijms140917986 JinHJ BaeYK KimM KwonSJ JeonHB ChoiSJ Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy Int J Mol Sci 2013 14 17986 8001 10.3390/ijms140917986 Open DOISearch in Google Scholar

33. Primorac D, Molnar V, Matisic V, Hudetz D, Jelec Z, Rod E, et al. Comprehensive review of knee osteoarthritis pharmacological treatment and the latest professional societies’ guidelines. Pharmaceuticals 2021; 14: 205. doi: 10.3390/ph14030205 PrimoracD MolnarV MatisicV HudetzD JelecZ RodE Comprehensive review of knee osteoarthritis pharmacological treatment and the latest professional societies’ guidelines Pharmaceuticals 2021 14 205 10.3390/ph14030205 Open DOISearch in Google Scholar

34. Lim JY, Ra JC, Shin IS, Jang YH, An HY, Choi JS, et al. Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage. PLoS One 2013; 8: e71167. doi: 10.1371/journal.pone.0071167 LimJY RaJC ShinIS JangYH AnHY ChoiJS Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage PLoS One 2013 8 e71167 10.1371/journal.pone.0071167 Open DOISearch in Google Scholar

35. Lim JY, Yi T, Choi JS, Jang YH, Lee S, Kim HJ, et al. Intraglandular transplantation of bone marrow-derived clonal mesenchymal stem cells for amelioration of post-irradiation salivary gland damage. Oral Oncol 2013; 49: 136–43. doi: 10.1016/j.oraloncology.2012.08.010 LimJY YiT ChoiJS JangYH LeeS KimHJ Intraglandular transplantation of bone marrow-derived clonal mesenchymal stem cells for amelioration of post-irradiation salivary gland damage Oral Oncol 2013 49 136 43 10.1016/j.oraloncology.2012.08.010 Open DOISearch in Google Scholar

36. Andrzejewska A, Lukomska B, Janowski M. Concise review: mesenchymal stem cells: from roots to boost. Stem Cells 2019; 37: 855–64. doi: 10.1002/stem.3016 AndrzejewskaA LukomskaB JanowskiM Concise review: mesenchymal stem cells: from roots to boost Stem Cells 2019 37 855 64 10.1002/stem.3016 Open DOISearch in Google Scholar

37. Grønhøj C, Jensen DH, Vester-Glowinski P, Jensen SB, Bardow A, Oliveri RS, et al. Safety and efficacy of mesenchymal stem cells for radiation-induced xerostomia: a randomized, placebo controlled phase 1/2 trial (MESRIX). Int J Radiat Oncol Biol Phys 2018; 101: 581–92. doi: 10.1016/j.ijrobp.2018.02.034 GrønhøjC JensenDH Vester-GlowinskiP JensenSB BardowA OliveriRS Safety and efficacy of mesenchymal stem cells for radiation-induced xerostomia: a randomized, placebo controlled phase 1/2 trial (MESRIX) Int J Radiat Oncol Biol Phys 2018 101 581 92 10.1016/j.ijrobp.2018.02.034 Open DOISearch in Google Scholar

38. Lynggaard CD, Gronhoj C, Jensen SB, Christensen R, Specht L, Andersen E, et al. Long-term safety of treatment with autologous mesenchymal stem cells in patients with radiation-induced xerostomia: primary results of the MESRIX phase I/II randomized trial. Clin Cancer Res 2022; 28: 2890–7. doi: 10.1158/1078-0432.CCR-21-4520 LynggaardCD GronhojC JensenSB ChristensenR SpechtL AndersenE Long-term safety of treatment with autologous mesenchymal stem cells in patients with radiation-induced xerostomia: primary results of the MESRIX phase I/II randomized trial Clin Cancer Res 2022 28 2890 7 10.1158/1078-0432.CCR-21-4520 Open DOISearch in Google Scholar

39. Lynggaard CD, Gronhoj C, Christensen R, Fischer-Nielsen A, Melchiors J, Specht L, et al. Intraglandular off-the-shelf allogeneic mesenchymal stem cell treatment in patients with radiation-induced xerostomia: a safety study (MESRIX-II). Stem Cells Transl Med 2022; 11: 478–89. doi: 10.1093/stcltm/szac011 LynggaardCD GronhojC ChristensenR Fischer-NielsenA MelchiorsJ SpechtL Intraglandular off-the-shelf allogeneic mesenchymal stem cell treatment in patients with radiation-induced xerostomia: a safety study (MESRIX-II) Stem Cells Transl Med 2022 11 478 89 10.1093/stcltm/szac011 Open DOISearch in Google Scholar

40. Lakota J, Dubrovcakova M, Haider KH. Human mesenchymal stem cells: the art to use them in the treatment of previously untreatable. In: Haider KH, editor. Handbook of stem cell therapy. Singapore: Springer Singapore; 2022. p. 1–20. doi: 10.1007/978-981-16-6016-0 LakotaJ DubrovcakovaM HaiderKH Human mesenchymal stem cells: the art to use them in the treatment of previously untreatable In: HaiderKH editor. Handbook of stem cell therapy Singapore Springer Singapore 2022 1 20 10.1007/978-981-16-6016-0 Open DOISearch in Google Scholar

41. Blitzer GC, Rogus-Pulia NM, Mattison RJ, Varghese T, Ganz O, Chappell R, et al. Marrow-derived autologous stromal cells for the restoration of salivary hypofunction (MARSH): study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer. Cytotherapy 2022; 24: 534–43. doi: 10.1016/j.jcyt.2021.11.003 BlitzerGC Rogus-PuliaNM MattisonRJ VargheseT GanzO ChappellR Marrow-derived autologous stromal cells for the restoration of salivary hypofunction (MARSH): study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer Cytotherapy 2022 24 534 43 10.1016/j.jcyt.2021.11.003 Open DOISearch in Google Scholar

42. Blitzer GC, Glazer T, Burr A, Gustafson S, Ganz O, Meyers R, et al. Marrow-derived autologous stromal cells for the restoration of salivary hypofunction (MARSH): a pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia. Cytotherapy 2023. [Ahead of print]. doi: 10.1016/j.jcyt.2023.07.009 BlitzerGC GlazerT BurrA GustafsonS GanzO MeyersR Marrow-derived autologous stromal cells for the restoration of salivary hypofunction (MARSH): a pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia Cytotherapy 2023 [Ahead of print]. 10.1016/j.jcyt.2023.07.009 Open DOISearch in Google Scholar

43. Moretti P, Hatlapatka T, Marten D, Lavrentieva A, Majore I, Hass R, et al. Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications. Adv Biochem Eng Biotechnol 2010; 123: 29–54. doi: 10.1007/10_2009_15 MorettiP HatlapatkaT MartenD LavrentievaA MajoreI HassR Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications Adv Biochem Eng Biotechnol 2010 123 29 54 10.1007/10_2009_15 Open DOISearch in Google Scholar

44. Bárcia RN, Santos JM, Filipe M, Teixeira M, Martins JP, Almeida J, et al. What makes umbilical cord tissue-derived mesenchymal stromal cells superior immunomodulators when compared to bone marrow derived mesenchymal stromal cells? Stem Cells Int 2015; 2015: 583984. doi: 10.1155/2015/583984 BárciaRN SantosJM FilipeM TeixeiraM MartinsJP AlmeidaJ What makes umbilical cord tissue-derived mesenchymal stromal cells superior immunomodulators when compared to bone marrow derived mesenchymal stromal cells? Stem Cells Int 2015 2015 583984 10.1155/2015/583984 Open DOISearch in Google Scholar

45. Kehl D, Generali M, Mallone A, Heller M, Uldry AC, Cheng P, et al. Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential. NPJ Regen Med 2019; 4: 8. doi: 10.1038/s41536-019-0070-y KehlD GeneraliM MalloneA HellerM UldryAC ChengP Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential NPJ Regen Med 2019 4 8 10.1038/s41536-019-0070-y Open DOISearch in Google Scholar

46. Doi H, Kitajima Y, Luo L, Yan C, Tateishi S, Ono Y, et al. Potency of umbilical cord blood and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing. Sci Rep 2016; 6: 18844. doi: 10.1038/srep18844 DoiH KitajimaY LuoL YanC TateishiS OnoY Potency of umbilical cord blood and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing Sci Rep 2016 6 18844 10.1038/srep18844 Open DOISearch in Google Scholar

47. Grønhøj C, Jensen DH, Glovinski PV, Jensen SB, Bardow A, Oliveri RS, et al. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial. Trials 2017; 18: 108. doi: 10.1186/s13063-017-1856-0 GrønhøjC JensenDH GlovinskiPV JensenSB BardowA OliveriRS First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial Trials 2017 18 108 10.1186/s13063-017-1856-0 Open DOISearch in Google Scholar